Dosing of antirheumatic drugs in renal disease and dialysis

Journal of Clinical Rheumatology

Volumn 10, Issue 4, 2004, Pages 190-204

  Swarup, Areena ^a,b   Sachdeva, Namita ^b   Schumacher Jr , H Ralph ^c,d  

^a Arizona Arthr/Rheumatology Assoc   (United States)

^b Wall Street Internal Medicine ^*  (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

^d VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Drug dosing; Gout; Hemodialysis; Renal insufficiency; Rheumatoid arthritis

Indexed keywords

ADALIMUMAB; ALLOPURINOL; ANTIMALARIAL AGENT; ANTIRHEUMATIC AGENT; AURANOFIN; AZATHIOPRINE; CELECOXIB; CHLOROQUINE; COLCHICINE; CYCLOOXYGENASE 2 INHIBITOR; CYCLOPHOSPHAMIDE; CYCLOSPORIN; DIFLUNISAL; ETANERCEPT; GOLD; HYDROXYCHLOROQUINE; INFLIXIMAB; KETOROLAC; LEFLUNOMIDE; MERCAPTOPURINE; METHOTREXATE; MINOCYCLINE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; NABUMETONE; NONSTEROID ANTIINFLAMMATORY AGENT; PENICILLAMINE; ROFECOXIB; SALAZOSULFAPYRIDINE; SULINDAC; UNINDEXED DRUG;

DIALYSIS; DOSE CALCULATION; DRUG DISPOSITION; DRUG EFFECT; DRUG INDUCED DISEASE; FLOW RATE; GASTROINTESTINAL TOXICITY; GOUT; HEMODIALYSIS; HUMAN; KIDNEY DISEASE; KIDNEY FAILURE; KIDNEY FUNCTION; MYOPATHY; NEPHROTOXICITY; PERITONEAL DIALYSIS; PRIORITY JOURNAL; REVIEW; RHEUMATIC DISEASE; SIDE EFFECT;

EID: 4043090493     PISSN: 10761608     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.rhu.0000135555.83088.a2     Document Type: Review

References (0)